INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA - Savara ( NASDAQ:SVRA )
NEW YORK, June 23, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Savara Inc. ( "Savara" or the "Company" ) SVRA. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA - Savara ( NASDAQ:SVRA )
NEW YORK, June 18, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Savara Inc. ( "Savara" or the "Company" ) SVRA. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA - Savara ( NASDAQ:SVRA )
NEW YORK, June 06, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Savara Inc. ( "Savara" or the "Company" ) SVRA. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
This Starbucks Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - GE Vernova ( NYSE:GEV ) , Salesforce ( NYSE:CRM )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA - Savara ( NASDAQ:SVRA )
NEW YORK, May 28, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Savara Inc. ( "Savara" or the "Company" ) SVRA. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Investigation of Savara Inc. ( SVRA ) Announced by Holzer & Holzer, LLC - Savara ( NASDAQ:SVRA )
ATLANTA, May 27, 2025 ( GLOBE NEWSWIRE ) -- Holzer & Holzer, LLC is investigating whether Savara Inc. ( "Savara" or the "Company" ) SVRA complied with federal securities laws.
Why Is Rare Lung Disease-Focused Savara Stock Trading Lower On Tuesday? - Savara ( NASDAQ:SVRA )
FDA cited incomplete CMC data in its refusal to file Molbreevi's BLA for autoimmune PAP treatment. Savara plans to resubmit the application in Q4 2025 following a Type A meeting with the FDA. Discover how Matt Maley trades sharp reversals-live this Wednesday, May 28 at 6 PM ET. Save your free ...
Dow Surges Over 600 Points; US Durable Goods Orders Fall in April - MAC Copper ( NYSE:MTAL ) , E2open Parent Holdings ( NYSE:ETWO )
U.S. stocks traded higher midway through trading, with the Dow Jones index jumping more than 600 points on Tuesday. President Donald Trump announced the extension of the 50% tariffs on Sunday till July 9, which he had initially announced on Friday.
BREAKING: Savara Shares Down Over 30%; Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses - Savara ( NASDAQ:SVRA )
BOSTON, May 27, 2025 ( GLOBE NEWSWIRE ) -- Block & Leviton is investigating Savara Inc. SVRA for potential securities law violations. Investors who have lost money in their Savara Inc. investment should contact the firm to learn more about how they might recover those losses.
Nasdaq Jumps Over 300 Points On EU Tariff Delay; AutoZone Posts Downbeat Earnings - E-Home Household Service ( NASDAQ:EJH ) , AutoZone ( NYSE:AZO )
U.S. stocks traded higher this morning, with the Nasdaq Composite surging more than 300 points on Tuesday. President Donald Trump announced the extension of the 50% tariffs on Sunday till July 9, which he had initially announced on Friday.
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Summit Therapeutics ( NASDAQ:SMMT )
Shares of Summit Therapeutics Inc. SMMT rose sharply in today's pre-market trading after the company said Ivonescimab Monotherapy reduced the risk of disease progression or death by 49% compared to pembrolizumab monotherapy in first-line treatment of patients with PD-L1 positive advanced NSCLC in ...
Why Is Respiratory Disease-Focused Savara Stock Trading Higher On Wednesday? - Savara ( NASDAQ:SVRA )
The latest trial study from Savara Inc SVRA met its primary endpoint. The company released results from Phase 3 IMPALA-2 trial of molgramostim 300 mcg administered once daily by inhalation with a matching placebo for autoimmune pulmonary alveolar proteinosis ( aPAP ) .
Barnwell Industries And 3 Other Stocks Under $3 Insiders Are Aggressively Buying - Near Intelligence ( NASDAQ:NIR ) , Bioventus ( NASDAQ:BVS )
The Dow Jones closed higher by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Why Shares of Savara Jumped on Tuesday
The company released first-quarter earnings and said it had completed a phase 3 trial enrollment for its lead therapy.
JD.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Credit Suisse Group ( NYSE:CS ) , Aurora Innovation ( NASDAQ:AUR )
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today's pre-market trading session. JD.com, Inc. JD shares dropped 8.1% to $48.72 in pre-market following a media report that the company is planning a $1.5 billion subsidy campaign to compete against rivals.
Why Shares of Savara Soared This Week
The clinical-stage biopharmaceutical company focuses on therapies to treat rare respiratory diseases.
$1.2 Million Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying - Clearday ( OTC:CLRD ) , Aspen Gr ( NASDAQ:ASPU )
The Dow Jones edged lower on the first trading session of 2023. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.
Wrap 2022: Here's the list of top 5 most discussed CFO resignations - ETCFO
From the curious case of Nykaa CFO's resignation, following the company's controversial bonus issue, to SpiceJet CFO exit in mid of widening losses, CFO world witnessed some unprecedented resignations in 2022. Also many big names in the CFO community resigned for better opportunities outside ...
Zomato sees a series of resignations. How worried should investors be?
Mohit Gupta's exit follows that of Rahul Ganjoo, Head of New Initiatives, and Siddharth Jhawar, Head of Intercity Legends. In August, Nitin Savara, Deputy CFO, resigned to start something new.
Philip Morris appoints two former U.S. FDA officials to key roles
Register now for FREE unlimited access to Reuters.com Register A woman poses with a cigarette in front of Philip Morris International logo in this illustration taken July 26, 2022. REUTERS/Dado Ruvic/Illustration Sept 14 ( Reuters ) - Philip Morris International Inc ( PM.N ) said on Wednesday it ...
Zacks.com featured highlights include Savara, The LGL Group, and Harte Hanks
Savara, The LGL Group, and Harte Hanks are part of zacks Screen of the Week article.
3 Top Breakout Stocks to Add to Your Portfolio Now
Savara (SVRA), LGL Group (LGL) and Harte Hanks (HHS) have been selected as the breakout stocks for today.
Has Assertio ( ASRT ) Outpaced Other Medical Stocks This Year?
Here is how Assertio (ASRT) and Savara Inc. (SVRA) have performed compared to their sector so far this year.
After Golden Cross, Savara Inc. ( SVRA ) 's Technical Outlook is Bright
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
The Daily Biotech Pulse: WHO Endorses Pfizer's Oral COVID Therapy, Vallon Pharma Surges On Strategic Review, Novavax Starts Dosing In Adolescents COVID Booster Trial
Here's a roundup of top developments in the biotech space over the last 24 hours.
Stocks In Focus
WHO Backs Pfizer's Oral COVID Antiviral Therapy For High-Risk Patients
The World Health Organization ( WHO ) endorsed Pfizer Inc's ( NYSE: PFE ) oral COVID-19 antiviral treatment in high-risk patien
